iBio IBIO
NASDAQ IBIO
$1.47 +0.00 (+0.29%)
As of: Aug 21, 2026 · 10:33 AM EDT

iBio (IBIO) Return on Sales (2011 - 2026)

iBio (IBIO) posted quarterly Return on Sales of 0.92% for Q1 2026, down 44.0% year-over-year from 1.64% in Q1 2025, and down 11.79% quarter-over-quarter from 0.82% in Q4 2025.

iBio (IBIO) Return on Sales (2011 - 2026) Analysis & Trends

iBio (IBIO) has reported Return on Sales for 16 consecutive years, with 0.92% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Return on Sales fell 44.0% year-over-year to 0.92%; the TTM figure through Mar 2026 stood at 0.92% (down 44.0% YoY), while the FY2025 annual figure was 2.04%, down 162.0% from the prior year.
  • Return on Sales declined to 0.92% in Q1 2026 per IBIO's latest filing, from 0.82% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.03% in Q1 2022 and bottomed at 1.3% in Q4 2023.
  • Historically, Return on Sales has averaged 0.5% across 5 years, with a median of 0.26% in 2024.
  • Annual changes were most pronounced in 2023 — Return on Sales slumped 105 bps — and 2024, when it soared 108 bps.
  • iBio's Return on Sales stood at 0.25% in 2022, then sank by 411 bps to 1.3% in 2023, then jumped by 83 bps to 0.22% in 2024, then plunged by 269 bps to 0.82% in 2025, then decreased by 12 bps to 0.92% in 2026.
  • Business Quant data shows IBIO's Return on Sales at 0.92% in Q1 2026, 0.82% in Q4 2025, and 0.57% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Vertex Pharmaceuticals 140.00 Bn 132.14 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 86.31 Bn 78.32 Bn 3.93 Bn 0.00%
3 Argenx Se 65.24 Bn 60.06 Bn 1.37 Bn 0.00%
4 Moderna 62.41 Bn 57.27 Bn 52.00 Mn -0.05%
5 BeOne Medicines 42.25 Bn 37.15 Bn 1.53 Bn 0.00%
6 Alnylam Pharmaceuticals 31.18 Bn 27.88 Bn 992.69 Mn 0.00%
7 BioNTech SE 28.93 Bn 10.54 Bn 668.28 Mn 0.00%
8 Insmed 27.55 Bn 26.39 Bn 358.27 Mn 0.00%
9 Royalty Pharma 27.28 Bn 26.44 Bn - 0.00%
10 iBio 177.01 Mn 177.01 Mn - -0.92%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.92%
Dec 31, 2025 -0.82%
Sep 30, 2025 -0.57%
Jun 30, 2025 -0.24%
Mar 31, 2025 -0.48%
Dec 31, 2024 -0.22%
Sep 30, 2024 -0.73%
Jun 30, 2024 -0.26%
Mar 31, 2024 -1.21%
Dec 31, 2023 -1.30%
Sep 30, 2023 -0.13%
Dec 31, 2022 -0.25%
Sep 30, 2022 -0.15%
Jun 30, 2022 -0.11%
Mar 31, 2022 -0.03%
Dec 31, 2021 -0.20%
Sep 30, 2021 -0.45%
Jun 30, 2021 -0.21%
Mar 31, 2021 -0.10%
Dec 31, 2020 -0.12%